[ad_1]
Phibro Animal Health Co. (NASDAQ:PAHC – Get Rating) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totalling 459,900 shares, an increase of 19.4% from the November 30th total of 385,300 shares. Based on an average trading volume of 183,600 shares, the short-interest ratio is currently 2.5 days. Currently, 2.3% of the company’s shares are sold short.
Analyst Ratings Changes
Several research analysts have recently weighed in on the company. StockNews.com lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Friday, November 11th. Morgan Stanley lowered their price objective on Phibro Animal Health from $21.00 to $20.00 and set an “equal weight” rating for the company in a research report on Thursday, November 10th. Barclays lowered their price objective on Phibro Animal Health from $22.00 to $17.00 and set an “underweight” rating for the company in a research report on Friday, September 16th. Finally, Roth Capital began coverage on Phibro Animal Health in a research report on Wednesday, December 21st. They issued a “buy” rating and a $18.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, Phibro Animal Health has an average rating of “Hold” and an average target price of $18.33.
Hedge Funds Weigh In On Phibro Animal Health
Hedge funds have recently added to or reduced their stakes in the stock. KBC Group NV acquired a new position in Phibro Animal Health during the 2nd quarter valued at about $30,000. UBS Group AG boosted its stake in Phibro Animal Health by 3,713.7% during the 3rd quarter. UBS Group AG now owns 4,462 shares of the company’s stock valued at $59,000 after purchasing an additional 4,345 shares during the last quarter. Gladius Capital Management LP acquired a new position in Phibro Animal Health during the 2nd quarter valued at about $68,000. Tower Research Capital LLC TRC boosted its stake in shares of Phibro Animal Health by 430.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 5,378 shares of the company’s stock worth $71,000 after buying an additional 4,364 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky purchased a new position in shares of Phibro Animal Health in the 3rd quarter worth approximately $71,000. Institutional investors and hedge funds own 49.21% of the company’s stock.
Phibro Animal Health Stock Down 0.4 %
Phibro Animal Health stock traded down $0.05 during midday trading on Friday, reaching $13.41. The stock had a trading volume of 111,903 shares, compared to its average volume of 181,734. Phibro Animal Health has a 12 month low of $11.75 and a 12 month high of $22.16. The company has a market capitalization of $543.11 million, a P/E ratio of 11.66, a PEG ratio of 7.36 and a beta of 0.58. The company has a fifty day moving average price of $13.33 and a two-hundred day moving average price of $15.61. The company has a current ratio of 3.30, a quick ratio of 1.68 and a debt-to-equity ratio of 1.72.
Phibro Animal Health Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Wednesday, December 21st. Shareholders of record on Wednesday, November 30th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, November 29th. This represents a $0.48 dividend on an annualized basis and a yield of 3.58%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 41.74%.
About Phibro Animal Health
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Phibro Animal Health, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Phibro Animal Health wasn’t on the list.
While Phibro Animal Health currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
[ad_2]
Source link
